The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1481
ISSUE1481
November 9, 2015
Addendum: Flibanserin (Addyi) for Hypoactive Sexual Desire Disorder
Download PDF: US English
Med Lett Drugs Ther. 2015 Nov 9;57(1481):156
Disclosures
Objective(s)
When our article on flibanserin (Addyi) was published (Med Lett Drugs Ther 2015; 57:133), the drug had not yet been marketed. Flibanserin became available on October 17, 2015 at a cost of $800 for a 30-day supply.
© The Medical Letter, Inc. All Rights Reserved.
The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and
complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any
damage resulting from any error, inaccuracy, or omission.
This article has been freely provided.
Previous article